Alexion Pharmaceuticals, Inc. (ALXN)
-NasdaqGS 102.67 
2.64(2.64%) May 21, 4:00PM EDT|After Hours
:
102.67 0.00 (0.00%) May 21, 4:25PM EDT
| Prev Close: | 100.03 |
|---|
| Open: | 100.42 |
|---|
| Bid: | 95.01 x 200 |
|---|
| Ask: | 104.66 x 100 |
|---|
| 1y Target Est: | 116.80 |
|---|
| Beta: | 0.54 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 100.03 - 102.87 |
|---|
| 52wk Range: | 81.82 - 119.54 |
|---|
| Volume: | 1,020,276 |
|---|
| Avg Vol (3m): | 1,669,230 |
|---|
| Market Cap: | 20.04B |
|---|
| P/E (ttm): | 70.47 |
|---|
| EPS (ttm): | 1.46 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Bayer Files Riociguat in JapanZacks(Tue, May 21)
- Yet Another Acquisition for BayerZacks(Tue, May 21)
- Despite Large Gains, This Stock Is Still a Buyat Motley Fool(Mon, May 20)
- S&P 500 Growth Stocks Portfolio That Can Outperform The Market By A Big Marginat Seeking Alpha(Mon, May 20)
- 5 Stocks Underperforming Today In The Drugs Industryat TheStreet(Mon, May 20)
- Biogen's Hemophilia BLA AcceptedZacks(Mon, May 20)
- Bayer's Xofigo Cleared in the USZacks(Thu, May 16)
- Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Drugs Laggardat TheStreet(Thu, May 16)
- A Fundamental, Bottom-Up Approach to Investing in Health Care: Portfolio Manager Finny Kuruvilla Discusses His Strategies with The Wall Street TranscriptWall Street Transcript(Thu, May 16)
- Big 5 Sporting Director Sells More Than 56K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet(Thu, May 16)
- 3 Stocks Underperforming Today In The Drugs Industryat TheStreet(Wed, May 15)
- AptarGroup CEO Sells 35K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet(Wed, May 15)
- [$$] Biotech Fund: Many Healthy Returnsat Barrons.com(Tue, May 14)
- Today's 3 Best Stocksat Motley Fool(Fri, May 10)
- Cramer: Biotech Makes a Comebackat TheStreet(Fri, May 10)
Key Statistics
| Forward P/E (1 yr): | 31.49 |
|---|
| P/S (ttm): | 15.89 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.92 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.67 |
|---|
| Mean Recommendation*: | 1.8 |
|---|
| PEG Ratio (5 yr expected): | 1.51 |
|---|
Business Summary
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of life-transforming therapeutic products.
View More